Pharmacovigilance–The next chapter
N Moore, D Berdaï, P Blin, C Droz - Therapies, 2019 - Elsevier
The discovery and quantification of adverse drug reactions has long relied on the careful
analysis of spontaneously reported cases. Causality assessment (imputation) was a …
analysis of spontaneously reported cases. Causality assessment (imputation) was a …
Uses of pharmacovigilance databases: an overview
K Bihan, B Lebrun-Vignes, C Funck-Brentano… - Therapies, 2020 - Elsevier
Over the past decades, assessment of drug safety and of their benefits harms balance has
been profoundly modified by the availability of large databases and computerized …
been profoundly modified by the availability of large databases and computerized …
Case–non-case studies: principle, methods, bias and interpretation
JL Faillie - Therapies, 2019 - Elsevier
Case–non-case studies are among the methods used to assess drug safety by analyzing the
disproportionality of adverse drug reaction reports in pharmacovigilance databases. First …
disproportionality of adverse drug reaction reports in pharmacovigilance databases. First …
Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA adverse event reporting system (AERS)
E Poluzzi, E Raschi, C Piccinni… - Data mining applications …, 2012 - books.google.com
Drug use in medicine is based on a balance between expected benefits (already
investigated before marketing authorization) and possible risks (ie, adverse effects), which …
investigated before marketing authorization) and possible risks (ie, adverse effects), which …
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
A Revet, F Montastruc, A Roussin, JP Raynaud… - BMC psychiatry, 2020 - Springer
Background Antidepressants-induced movement disorders are rare and imperfectly known
adverse drug reactions. The risk may differ between different antidepressants and …
adverse drug reactions. The risk may differ between different antidepressants and …
Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World
JT Campillo, M Boussinesq, S Bertout… - PLoS Neglected …, 2021 - journals.plos.org
Background Ivermectin is known to cause severe encephalopathies in subjects infected with
loiasis, an endemic parasite in Sub-Saharan Africa (SSA). In addition, case reports have …
loiasis, an endemic parasite in Sub-Saharan Africa (SSA). In addition, case reports have …
[HTML][HTML] Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA adverse event reporting system
C Teng, KR Reveles… - … Journal of Medical …, 2019 - ncbi.nlm.nih.gov
Introduction: Antibiotic use is an important risk factor for Clostridium difficile infection (CDI).
Prior meta-analyses have identified antibiotics and antibiotic classes that pose the greatest …
Prior meta-analyses have identified antibiotics and antibiotic classes that pose the greatest …
Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system
E Raschi, E Poluzzi, A Koci, F Salvo… - British journal of …, 2015 - Wiley Online Library
Aim We assessed the hepatic safety of novel oral anticoagulants (NOACs) analyzing the
publicly available US‐FDA adverse event reporting system (FAERS). Methods We extracted …
publicly available US‐FDA adverse event reporting system (FAERS). Methods We extracted …
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26. COV2. S, and mRNA-1273: gaining insight through the VAERS
MM Yan, H Zhao, ZR Li, JW Chow, Q Zhang… - Frontiers in …, 2022 - frontiersin.org
Background and purpose: Serious adverse events following immunization (AEFI) associated
with the COVID-19 vaccines, including BNT162b2 (Pfizer-BioNTech), Ad26. COV2. S …
with the COVID-19 vaccines, including BNT162b2 (Pfizer-BioNTech), Ad26. COV2. S …
常用药品不良反应信号检测方法介绍
任经天, 王胜锋, 侯永芳, 杜晓曦… - 中国药物警戒, 2011 - zgywjj.magtechjournal.com
常用药品不良反应信号检测方法介绍 首页 期刊介绍 栏目设置 编委会 投稿指南 道德声明 期刊
订阅 联系我们 期刊合作 English 中国药物警戒 ›› 2011, Vol. 8 ›› Issue (5): 294-298. • 管理及 …
订阅 联系我们 期刊合作 English 中国药物警戒 ›› 2011, Vol. 8 ›› Issue (5): 294-298. • 管理及 …